Implantable defibrillator‐detected heart failure status predicts ventricular tachyarrhythmias

Abstract

AbstractIntroductionThe prediction of ventricular tachyarrhythmias among patients with implantable cardioverter defibrillators is difficult with available clinical tools. We sought to assess whether in patients with heart failure (HF) and reduced ejection fraction with defibrillators, physiological sensor‐based HF status, as summarized by the HeartLogic index, could predict appropriate device therapies.MethodsFive hundred and sixty‐eight consecutive HF patients with defibrillators (n = 158, 28%) or cardiac resynchronization therapy‐defibrillators (n = 410, 72%) were included in this prospective observational multicenter analysis. The association of both HeartLogic index and its physiological components with defibrillator shocks and overall appropriate therapies was assessed in regression and time‐dependent Cox models.ResultsOver a follow‐up of 25 (15–35) months, 122 (21%) patients received an appropriate device therapy (shock, n = 74, 13%), while the HeartLogic index crossed the threshold value (alert, HeartLogic ≥ 16) 1200 times (0.71 alerts/patient‐year) in 370 (65%) subjects. The occurrence of ≥1 HeartLogic alert was significantly associated with both appropriate shocks (Hazard ratios [HR]: 2.44, 95% confidence interval [CI]: 1.49–3.97, p = .003), and any appropriate defibrillator therapies. In multivariable time‐dependent Cox models, weekly IN‐alert state was the strongest predictor of appropriate defibrillator shocks (HR: 2.94, 95% CI: 1.73–5.01, p < .001) and overall therapies. Compared with stable patients, patients with appropriate shocks had significantly higher values of HeartLogic index, third heart sound amplitude, and resting heart rate 30–60 days before device therapy.ConclusionThe HeartLogic index is an independent dynamic predictor of appropriate defibrillator therapies. The combined index and its individual physiological components change before the arrhythmic event occurs.